Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01698905 |
| Title | Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop) (ENESTop) |
| Acronym | ENESTop |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | POL | ISR | GRC | GBR | FRA | ESP | DEU | CAN | BRA | BEL | AUS | ARG |